LXEO Lexeo Therapeutics10.18+0.71 (+7.5%)
Premarket Decliner
LXEO Lexeo Therapeutics17.60+0.16+0.9%
Premarket:14.51-3.09 (-17.6%)
Lexeo Therapeutics Announces Positive Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
Globe NewswireMon, 15-Jul 6:00 AM